Metagenomic next‐generation sequencing (mNGS) is revolutionising infectious disease diagnosis by enabling an unbiased interrogation of all genetic material within a clinical sample. This approach ...

DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

Next-generation sequencing (NGS) has transformed genomic research and clinical diagnostics by enabling rapid, high-throughput analysis of genetic material. The application of NGS to formalin-fixed ...

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has ...

Next-generation sequencing (NGS) has revolutionized genomics, empowering scientists with a powerful tool to sequence millions of DNA fragments at once. This transformative technology has increased the ...

Integrating metagenomics and bioinformatics enhances food safety, enabling early detection of microbial risks and supporting ...

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Global Immune Repertoire Sequencing Market OverviewThe global immune repertoire sequencing market is projected to expand at a steady compound annual growth rate of approximately 10% during the ...